RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia

Journal of Clinical Psychopharmacology
Hsien-Yuan LaneGuochuan E Tsai

Abstract

Polymorphisms of the gene encoding the regulator of G-protein signaling subtype 4 (RGS4) are associated with schizophrenia. This study aims to investigate the association of 4 RGS4 polymorphisms (single nucleotide polymorphisms [SNPs] 1, 4, 7, and 18), implicated in previous studies, with baseline symptoms and treatment response to risperidone in patients with schizophrenia. One hundred twenty patients with acutely exacerbated schizophrenia who had never been treated by atypical antipsychotics were recruited. They received optimal treatment of risperidone for up to 42 days in the inpatient research unit. Patients' social functions were monitored by Nurses' Observation Scale for Inpatients Evaluation and clinical manifestations, by Positive and Negative Syndrome Scale. At baseline status, the A/A genotype at SNP7 of RGS4 was associated with poorer social function when compared with the G/G genotype. After risperidone treatment, the A/A genotype at SNP1 was associated with greater improvement at social function, and the A/A genotype at SNP18 was associated with greater improvement at social function, Positive and Negative Syndrome Scale total score, and positive- and negative-symptom subscale. These findings suggest that RGS4 var...Continue Reading

References

Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
May 19, 2000·The Journal of Clinical Psychiatry·H Y LaneW H Chang
Aug 28, 2001·Nucleic Acids Research·S YeI N Day
May 25, 2002·Human Molecular Genetics·Kodavali V ChowdariVishwajit L Nimgaonkar
Sep 10, 2002·Psychiatric Genetics·Fiona E A McGuigan, Stuart H Ralston
Jul 21, 2004·Molecular Psychiatry·P J Harrison, D R Weinberger
Jan 8, 2005·Genetic Epidemiology·Kathryn RoederB Devlin
Feb 14, 2006·Schizophrenia Bulletin·Michael E TalkowskiVishwajit L Nimgaonkar
Aug 19, 2006·Schizophrenia Bulletin·Shannon M CoutureDavid L Roberts

❮ Previous
Next ❯

Citations

Oct 8, 2008·Development and Psychopathology·Katherine H KarlsgodtTyrone D Cannon
Aug 30, 2008·Schizophrenia Bulletin·Maria J Arranz, Shitij Kapur
Nov 26, 2009·Schizophrenia Bulletin·Colm M P O'TuathaighJohn L Waddington
Jun 26, 2009·Current Opinion in Psychiatry·Sibylle G Schwab, Dieter B Wildenauer
Jan 27, 2011·Psychiatry and Clinical Neurosciences·Ramón CacabelosMasatoshi Takeda
Jun 27, 2009·Annual Review of Neuroscience·T W Robbins, A F T Arnsten
May 10, 2008·Pharmacogenomics·Daniel B Campbell, Pat Levitt
Dec 18, 2013·Pharmacogenomics·Evangelia Eirini TsermpiniGeorge P Patrinos
Jan 19, 2013·Pharmacogenomics·Adrián LlerenaHumberto Fariñas
Feb 22, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Rachel E Kneeland, S Hossein Fatemi
Sep 14, 2010·Clinics in Laboratory Medicine·Peter P Zandi, Jennifer T Judy
Feb 18, 2010·The Psychiatric Clinics of North America·Peter P Zandi, Jennifer T Judy
Jan 31, 2013·Bipolar Disorders·Haiming ChenMelvin G McInnis
Aug 28, 2014·Journal of Traumatic Stress·Erika J WolfMark W Miller
Dec 3, 2014·European Journal of Pharmacology·Barbara J CaldaroneSarah L King
May 21, 2013·Schizophrenia Research·Ali Bani-FatemiVincenzo De Luca
May 26, 2017·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Emanuel Schwarz
Sep 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Levi L Blazer, Richard R Neubig
Nov 26, 2011·Expert Review of Clinical Pharmacology·Maria J Arranz, Janet C Munro
Aug 20, 2014·TheScientificWorldJournal·Zhi-hui NiWu Li-chun
Dec 28, 2019·Pharmaceutics·Stefano FortinguerraAlessandro Buriani
Apr 24, 2018·Psychiatry Research·Alireza MohammadiVahid Ghasem Amooeian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here